INVEST Precision Medicine Pitch Perfect Health IT and Life Science tracks video highlights
Video from the Health IT and Life Science tracks of our Pitch Perfect contest at INVEST Precision Medicine is now available to view.
Who won the startup pitch contest at INVEST Precision Medicine?
Ten companies presented an overview of their businesses in the health IT and life science tracks of Pitch Perfect. Two winners emerged. Here's a look at who won and why.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
INVEST Precision Medicine conference kicks off today. Register now to be part of the conversation.
Register for the INVEST Precision Medicine conference, which kicks off today. Over the next three days industry experts will talk about precision medicine developments across pediatrics, bioinformatics, startups and more.
Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy
The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology - currently in preclinical development - into human clinical trials. German drugmaker Bayer's venture capital arm led the round.
Irish software startup nabs $25M Series C to speed up clinical trials
The startup's platform is meant to digitize and modernize the still largely manually and paper-based process of running and managing clinical trials.